Hepatitis B

AASLD Hepatitis B Guidelines

AASLD Hepatitis B GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/88345

Contents of this Issue

Navigation

Page 14 of 19

HBeAg-Positive Patients ÎPerform ALT test at 3-6 month intervals for HBeAg-positive patients with persistently normal ALT. When ALT levels become elevated, test more often for ALT along with HBV DNA. Check HBeAg status every 6-12 months. (III) ÎConsider for liver biopsy patients who remain HBeAg positive with HBV DNA levels > 20,000 IU/mL after a 3-6 month period of elevated ALT levels between 1-2 × ULN, or who remain HBeAg positive with HBV DNA levels > 20,000 IU/mL and are > 40 years old. • Consider treatment if biopsy shows moderate/severe inflammation or significant fibrosis. (III) ÎConsider for treatment patients who remain HBeAg positive with HBV DNA levels > 20,000 IU/mL after a 3-6 month period of elevated ALT levels 2 × ULN. (III) HBeAg-Negative Patients ÎHBeAg-negative patients with normal ALT and HBV DNA < 2,000 IU/mL should be tested for ALT every 3 months during the first year to verify that they are truly in the "inactive carrier state" and then every 6-12 months. (III) ÎPerform tests for HBV DNA and initiate more frequent monitoring if ALT or AST increases above the normal limit. (III) 13

Articles in this issue

view archives of Hepatitis B - AASLD Hepatitis B Guidelines